Compare Packaging Corporation of America (PKG) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Sana Biotechnology Inc — how do they compare? Packaging Corporation of America trades at $227.95 (market cap $20.67B), while Sana Biotechnology Inc trades at $3.24 (market cap $1.03B). The key difference: Packaging Corporation of America is far larger — about 20.1× Sana Biotechnology Inc's market cap, and Packaging Corporation of America pays a 2.59% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| PKG | SANA | |
|---|---|---|
Market Cap | $20.67B | $1.03B |
Sector | Technology | Health |
52-Week High | $257.43 | $5.92 |
52-Week Low | $191.68 | $2.68 |
Enterprise Value | $24.48B | $946.04M |
Dividend Yield | 2.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $231.99, down 2.22% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with a P/E of 30.13 above industry averages, while profitability metrics indicate solid ROE of 14.79% amid margin pressures. Recent news highlights dividend declarations and CEO participation in industry conferences, though cash flow trends show negative net flows driven by significant capital investments.
PKG presents a cautious outlook with analyst consensus leaning hold (57.69%) despite a $272.83 price target suggesting 17.6% upside. Investment appeal hinges on execution amid cost headwinds, while risks include margin compression and competitive pressures. The technical setup near support at $230 requires monitoring for potential breakdown or reversal signals.
SANA Biotechnology trades at $3.45, down 10.39% in the past 24 hours, reflecting bearish technical signals and negative profitability. The company reported a net loss of $244.17 million for 2025, with a price-to-book ratio of 6.68. Recent news includes investor conference presentations and a peer-reviewed publication in The New England Journal of Medicine highlighting clinical data.
Despite analyst consensus favoring a 'Buy' rating (81.82% of 11 analysts), the stock faces significant risks from negative cash flows, high losses, and potential fiduciary concerns. Upside hinges on successful clinical developments and improved financial performance, but current fundamentals suggest caution for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
